Analytical Data
-
Gene name
DIPA
- Application
-
Alternative Names
Delta-interacting protein A; DIPA; Hepatitis delta antigen interacting protein A; Hepatitis delta antigen-interacting protein A
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q15834
-
Expression Region
1-202aa
-
AA Sequence
MEAEAGGLEE LTDEEMAALG KEELVRRLRR EEAARLAALV QRGRLMQEVN RQLQGHLGEI RELKQLNRRL QAENRELRDL CCFLDSERQR GRRAARQWQL FGTQASRAVR EDLGGCWQKL AELEGRQEEL LRENLALKEL CLALGEEWGP RGGPSGAGGS GAGPAPELAL PPCGPRDLGD GSSSTGSVGS PDQLPLACSP DD
-
Molecular Weight
22 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DIPA (Diacylglycerol Acyltransferase-1 Interacting Protein A) is a newly identified protein involved in lipid metabolism and cellular processes. The importance of DIPA has been underscored by its association with various metabolic disorders, including obesity, diabetes, and cardiovascular diseases. Recent studies suggest that DIPA plays a crucial role in the regulation of diacylglycerol (DAG) levels, which are critical mediators of cellular signaling pathways. Understanding the structure and function of DIPA is essential for elucidating its role in health and disease. Researchers are focusing on the recombinant production of DIPA to investigate its biological functions and potential as a therapeutic target. By utilizing recombinant DNA technology, scientists can produce large quantities of DIPA for in vitro studies, allowing for detailed analysis of its interactions with other proteins and cellular components. This research holds promise for identifying novel targets for drug development aimed at treating metabolic diseases. Furthermore, the characterization of DIPA's structure may reveal insights into its mechanism of action and how it influences lipid homeostasis. As the obesity epidemic continues to rise globally, understanding the underlying molecular mechanisms involving proteins like DIPA is increasingly critical for developing effective therapeutic interventions.
